Ad
related to: bcg
Search results
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 7 days agoBoston Consulting Group (BCG) today released its Annual Sustainability Report: From Bold Ideas to Exponential Impact. It also outlines BCG's progress toward ...
ImmunityBio partners with Serum Institute for BCG vaccines
Pharmaceutical Technology via Yahoo Finance· 4 days agoImmunityBio has entered an exclusive worldwide agreement with the Serum Institute of India to secure...
Asset Managers Need to Set a Strategy to Leverage the AI Opportunity and Drive Future Growth
WRBL Columbus· 20 hours agoThe global asset management industry bounced back in 2023. The industry's total assets under management (AuM) rose to nearly $120 trillion, an increase of 12% over 2022, a year that saw AuM plummet by 9%.
High Response Rates With Gene Therapies for BCG-Unresponsive Bladder Cancer
MedPage Today· 3 days agoThree-fourths of patients had complete responses, which proved to be durable in most cases
Johnson & Johnson Advances Its Two Bladder Cancer Studies, Releases Latest Data
Benzinga· 4 hours agoResults featured updated data from Cohort 1 (C1), patients with recurrent, Bacillus Calmette-Guérin...
Sustainable Fashion Forum Lays Out Challenges Ahead
Sourcing Journal via Yahoo News· 5 hours agoHowever, according to Samina Virk, North America CEO for Vestiaire Collective, this misconception is starting to shift. A study conducted by Vestiaire...
The most-picked March Madness champion every year since 2014
NCAA· 6 days agoThe Huskies repeated as national champs and became the first title team to be the most-picked BCG...
TAR-210 results show 90% recurrence-free survival and 90% complete response in patients with...
WROC Rochester· 1 day agoResults featured updated data from Cohort 1 (C1), patients with recurrent, Bacillus Calmette-Guérin...
TAR-200 monotherapy shows greater than 80% complete response rate in patients with high-risk...
WTNH-TV New Haven· 3 days agoJohnson & Johnson announced today updated results from Cohort 2 of the Phase 2b SunRISe-1 study...
...Present Details of its Pivotal Phase 1/2 LEGEND Study of EG-70 in BCG-Unresponsive Non-Muscle...
Fort Wayne Journal Gazette· 4 days ago(Nasdaq: ENGN) or ("enGene" or the "Company"), a clinical-stage genetic medicines company whose non-viral lead program EG-70 is in a pivotal study for BCG-unresponsive non-muscle ...
